Furthermore, to determine whether TGF-β and IL-33 are essential for the induction of Tff1-Tregs in vivo, we examined YFP expression during BLM treatment with IL-33 and TGF-β neutralizing antibodies. The gene discussed is TFF1; the disease is Bloom syndrome.